Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT alone versus concurrent cisplatin/5-fluorouracil chemoradiotherapy for postoperative nodal recurrence of esophageal cancer
ChiCTR-TRC-12002782Phase 3Completed
- Sponsor
- Anyang Cancer Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cisplatin and fluorouracil in esophageal cancer (2 arms), sponsored by Anyang Cancer Hospital. Primary endpoint: Progression-free survival. Started Nov 2012; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR-TRC-12002782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002782.